Meloxicam

Product manufactured by Redpharm Drug, Inc.

Application Nr Approved Date Route Status External Links
ANDA078008 2006-10-02 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage 1.1 Osteoarthritis (oa) Meloxicam Tablets Are Indicated For Relief Of The Signs And Symptoms Of Osteoarthritis [see Clinical Studies (14.1)]. 1.2 Rheumatoid Arthritis (ra) Meloxicam Tablets Are Indicated For Relief Of The Signs And Symptoms Of Rheumatoid Arthritis [see Clinical Studies (14.1)]. 1.3 Juvenile Rheumatoid Arthritis (jra) Pauciarticular And Polyarticular Course Meloxicam Tablets Are Indicated For Relief Of The Signs And Symptoms Of Pauciarticular Or Polyarticular Course Juvenile Rheumatoid Arthritis In Patients Who Weigh ≥60 Kg [see Dosage And Administration (2.4) And Clinical Studies (14.2)].

All Formulated Excipients (4 Total)

Name Structure Kind Function Status
1. Lactose Monohydrate LACTOSE MONOHYDRATE Molecular
2. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
3. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
4. Povidones POVIDONES Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Meloxicam MELOXICAM ZINC13129998

Comments